Home LiteratureArticle Details
PMID: 8627650 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.

Journal of virology ·Vol. 70 ·No. 3 ·1996-03-00 ·Pages 1340-54

Cao J, Park IW, Cooper A, Sodroski J

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of CD4-positive lymphocytes is accompanied by acute cytopathic effects, i.e., syncytium formation and single-cell lysis. Syncytium formation involves cell-cell fusion mediated by viral envelope glycoproteins on the surface of infected cells and by CD4 glycoproteins on adjacent cells. The molecular basis for the lysis of single-HIV-1 infected cells is unclear. Here we report that the expression of functional envelope glycoproteins from primary and laboratory-adapted HIV-1 isolates resulted in the lysis of single CD4-positive lymphocytes. As was previously observed in HIV-1 infected cultures, single-cell lysis in this system primarily involved necrosis and was not inhibited by soluble CD4. Binding of the viral envelope glycoproteins to the CD4 glycoprotein facilitated, but was not sufficient for, cytolysis. Importantly, the ability of the HIV-1 envelope glycoproteins to mediate membrane fusion was essential for single-cell killing. By contrast, the long cytoplasmic tail of the gp41 transmembrane envelope glycoprotein was neither necessary nor sufficient for single-cell lysis. These results suggest that intracellular envelope glycoprotein-CD4 interactions initiate autofusion events that disrupt cell membrane integrity, leading to single-cell lysis by HIV-1.

MeSH Terms
CD4-Positive T-Lymphocytes/ultrastructure,virology Cell Line Cytopathogenic Effect, Viral Gene Expression Gene Products, env/genetics,physiology HIV Envelope Protein gp120/genetics,physiology HIV Envelope Protein gp160 HIV Envelope Protein gp41/genetics,physiology HIV-1/genetics,physiology Humans Membrane Glycoproteins/genetics,physiology Mutation Protein Precursors/genetics,physiology Transfection
Chemicals
Gene Products, env HIV Envelope Protein gp120 HIV Envelope Protein gp160 HIV Envelope Protein gp41 Membrane Glycoproteins Protein Precursors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Cao J
Division of Human Retrovirology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Park I W
Cooper A
Sodroski J
References (83)
83 references, click to expand
  1. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    J Immunol. 1993 Dec 15;151(12):7337-48 PMID: 7903106
  2. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.
    AIDS Res Hum Retroviruses. 1993 Nov;9(11):1057-66 PMID: 8312049
  3. Programmed cell death and Bcl-2 protection in the absence of a nucleus.
    EMBO J. 1994 Apr 15;13(8):1899-910 PMID: 8168488
  4. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Virology. 1994 May 15;201(1):137-41 PMID: 8178478
  5. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  6. Changes in the cytopathic effects of human immunodeficiency virus type 1 associated with a single amino acid alteration in the ectodomain of the gp41 transmembrane glycoprotein.
    J Virol. 1994 Jul;68(7):4662-8 PMID: 8207841
  7. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
    Am J Pathol. 1994 Aug;145(2):330-7 PMID: 7519826
  8. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes.
    J Virol. 1994 Nov;68(11):7115-23 PMID: 7933093
  9. Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10237-41 PMID: 7937869
  10. Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals.
    Res Virol. 1994 May-Aug;145(3-4):171-6 PMID: 7800942
  11. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    N Engl J Med. 1995 Jan 26;332(4):201-8 PMID: 7808485
  12. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.
    J Virol. 1995 Feb;69(2):882-8 PMID: 7815556
  13. Viral dynamics in human immunodeficiency virus type 1 infection.
    Nature. 1995 Jan 12;373(6510):117-22 PMID: 7529365
  14. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Nature. 1995 Jan 12;373(6510):123-6 PMID: 7816094
  15. Depletion of calcium from the lumen of endoplasmic reticulum reversibly inhibits passive diffusion and signal-mediated transport into the nucleus.
    J Cell Biol. 1995 Jan;128(1-2):5-14 PMID: 7822421
  16. Apoptosis, oncosis, and necrosis. An overview of cell death.
    Am J Pathol. 1995 Jan;146(1):3-15 PMID: 7856735
  17. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).
    J Virol. 1995 May;69(5):2801-10 PMID: 7707502
  18. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
    J Virol. 1995 Jul;69(7):4413-22 PMID: 7769703
  19. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.
    Cell. 1988 May 6;53(3):483-96 PMID: 2966682
  20. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  21. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4297-301 PMID: 2424024
  22. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  23. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    J Immunol. 1986 Nov 1;137(9):2937-44 PMID: 2428879
  24. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
    Lancet. 1986 Sep 20;2(8508):660-2 PMID: 2429124
  25. Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.
    J Virol. 1986 Nov;60(2):754-60 PMID: 3490583
  26. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Nature. 1986 Oct 23-29;323(6090):725-8 PMID: 3095663
  27. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.
    Science. 1986 Nov 28;234(4780):1123-7 PMID: 3095925
  28. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion.
    J Virol. 1987 Oct;61(10):3114-9 PMID: 2957508
  29. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
    Science. 1987 Sep 11;237(4820):1351-5 PMID: 3629244
  30. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Nature. 1988 Jan 7;331(6151):78-81 PMID: 2829023
  31. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
    Science. 1988 Feb 5;239(4840):617-22 PMID: 3277274
  32. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis.
    Virology. 1988 Mar;163(1):43-51 PMID: 3126600
  33. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.
    Cell. 1988 Apr 8;53(1):55-67 PMID: 2450679
  34. Biologic features of HIV-1 that correlate with virulence in the host.
    Science. 1988 Apr 1;240(4848):80-2 PMID: 2832945
  35. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.
    J Virol. 1988 Nov;62(11):4414-9 PMID: 2459416
  36. Depletion of the surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human CD4+ monocytoid cell line.
    J Virol. 1989 Sep;63(9):3748-54 PMID: 2788223
  37. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    N Engl J Med. 1989 Dec 14;321(24):1621-5 PMID: 2586564
  38. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.
    J Immunol. 1990 Jan 1;144(1):94-102 PMID: 2404066
  39. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):648-52 PMID: 2300552
  40. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site.
    J Virol. 1990 May;64(5):2337-44 PMID: 2182911
  41. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
    J Virol. 1990 May;64(5):2416-20 PMID: 2325207
  42. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 PMID: 2191297
  43. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    J Virol. 1990 Aug;64(8):3792-803 PMID: 1695254
  44. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation.
    J Virol. 1990 Sep;64(9):4390-8 PMID: 2384920
  45. Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines.
    J Virol. 1990 Oct;64(10):4661-71 PMID: 2204721
  46. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.
    Nature. 1990 Nov 1;348(6296):69-73 PMID: 2172833
  47. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
    J Virol. 1990 Dec;64(12):5701-7 PMID: 2243375
  48. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
    J Virol. 1990 Dec;64(12):6314-8 PMID: 2243396
  49. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    J Virol. 1991 Jan;65(1):281-91 PMID: 1702159
  50. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
    J Virol. 1991 Apr;65(4):2047-55 PMID: 1900540
  51. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3097-101 PMID: 2014229
  52. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology.
    Virology. 1991 Apr;181(2):500-11 PMID: 1901681
  53. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.
    J Clin Invest. 1991 May;87(5):1710-5 PMID: 2022741
  54. Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus.
    J Virol. 1991 Oct;65(10):5609-12 PMID: 1895408
  55. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    J Virol. 1991 Nov;65(11):6129-36 PMID: 1717715
  56. The cytopathic effect of HIV is associated with apoptosis.
    Virology. 1991 Dec;185(2):829-39 PMID: 1683728
  57. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.
    J Virol. 1992 Apr;66(4):2389-97 PMID: 1548769
  58. Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry.
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2223-6 PMID: 1549586
  59. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
    J Biol Chem. 1992 Apr 5;267(10):7121-7 PMID: 1551918
  60. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    J Virol. 1992 Jun;66(6):3306-15 PMID: 1583717
  61. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
    J Virol. 1992 Jun;66(6):3971-5 PMID: 1583738
  62. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product.
    Virology. 1992 Jul;189(1):167-77 PMID: 1604808
  63. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547-51 PMID: 1319065
  64. Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.
    J Virol. 1992 Oct;66(10):5777-87 PMID: 1527842
  65. Studies on the pathogenesis of cell injury: effects of inhibitors of metabolism and membrane function on the mitochondria of Ehrlich ascites tumor cells.
    Lab Invest. 1975 Feb;32(2):163-82 PMID: 1113509
  66. On the nature of Romanowsky dyes and the Romanowsky-Giemsa effect.
    Clin Lab Haematol. 1979;1(4):247-62 PMID: 94558
  67. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
    Science. 1983 May 20;220(4599):868-71 PMID: 6189183
  68. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.
    Ann Intern Med. 1984 Jan;100(1):92-106 PMID: 6318629
  69. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  70. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
  71. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  72. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8 PMID: 6083454
  73. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    Science. 1986 Jan 24;231(4736):382-5 PMID: 3001934
  74. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
    Science. 1986 Mar 28;231(4745):1549-53 PMID: 3006244
  75. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
    J Virol. 1992 Dec;66(12):7517-21 PMID: 1433527
  76. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Virology. 1993 Feb;192(2):605-17 PMID: 8421902
  77. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.
    J Virol. 1993 Apr;67(4):1772-7 PMID: 8095306
  78. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  79. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.
    Cancer Res. 1993 Apr 15;53(8):1945-51 PMID: 8467513
  80. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    J Virol. 1993 Aug;67(8):4557-65 PMID: 8331723
  81. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.
    Virology. 1993 Sep;196(1):89-100 PMID: 8356808
  82. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.
    AIDS Res Hum Retroviruses. 1993 Aug;9(8):761-73 PMID: 8105835
  83. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.
    J Virol. 1994 Jan;68(1):390-9 PMID: 7504739
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-03-00
Pages
1340-54
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189953
Subset
IM
Grants
NIAID NIH HHS · AI24755 · United States
NIAID NIH HHS · AI28691 · United States
NCI NIH HHS · CA 06516 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com